The pathophysiological mechanisms of TAO are varied, involving the autoimmune activation of orbital fibroblasts by autoantibodies against the thyroid-stimulating hormone receptor (TSHR) and insulin-like growth factor 1 receptor (IGF-1R) [7,8]. The gene discussed is TSHR; the disease is thromboangiitis obliterans.